RevBio

About:

RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.

Website: https://revbio.com/

Twitter/X: RevBio_

Top Investors: National Institutes of Health, National Institute on Aging, National Institute of Neurological Disorders and Stroke, MassChallenge, MedTech Innovator

Description:

RevBio is commercializing an injectable, self-setting, osteoconductive bone adhesive biomaterial that can bond bone to bone and bone to metal in a wet field environment. The company's showcase product, Tetranite, is being reviewed by the FDA for a growing body of applications including oral, craniofacial, orthopedic, and neurosurgical indications. Over time, this synthetic adhesive biodegrades and is replaced by new bone. This unique material will reduce the duration and complexity of medical procedures, allow for more minimally invasive surgeries, and will improve patient outcomes by reducing recovery time and the overall cost of care.